Opportunity Information: Apply for PAR 14 178
Apply for PAR 14 178
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859 Biomedical Research and Research Training.
- This funding opportunity was created on Apr 24, 2014 and posted on Apr 24, 2014.
- Applicants must submit their applications by May 26, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) City or township governments Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers (P30) opportunity (Funding Opportunity Number PAR-14-178) is a discretionary NIH grant program designed to help established COBRE programs move from a period of structured, programmatic support into long-term independence and financial sustainability. In practical terms, the FOA focuses on transitioning a COBRE that has already built meaningful research capacity into a stable, self-sustaining center by maintaining and strengthening its shared core resources and the biomedical research activities that depend on those cores. This is a “Phase III” mechanism, meaning it is intended for COBRE centers that have progressed through earlier development stages and are now positioned to stand on their own, with NIH support serving as a bridge rather than a permanent subsidy.
The funding instrument is a P30 center core grant. P30 awards generally emphasize shared infrastructure, centralized resources, and services that enable multiple investigators to conduct higher-quality, more competitive research than they could manage individually. Under this FOA, the key idea is to keep essential COBRE-developed cores and research capabilities operating effectively while the institution and center leadership put durable plans in place for the center to continue without COBRE program support. “Transitional” is the operative word: NIH support is aimed at helping the center cross the gap between being COBRE-supported and being independently viable through other funding streams, institutional investment, user fees, partnerships, or other sustainable models.
The program was posted on April 24, 2014, with an original and final closing date of May 26, 2016, and an archive date of June 26, 2016. The award ceiling listed for this FOA is $750,000, and the catalog of federal domestic assistance (CFDA) number is 93.859 (Biomedical Research and Research Training). There is no cost sharing or matching requirement indicated, which means applicants are not required to commit non-federal funds as a formal condition of the award, although NIH center applications commonly describe institutional commitment and sustainability plans as part of competitive proposals.
Eligibility is broad across many U.S.-based organization types, reflecting NIH’s interest in supporting biomedical research infrastructure in a variety of settings. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), for-profit organizations other than small businesses, and small businesses. Governmental entities may apply as well, including state governments, county governments, city or township governments, special district governments, and certain housing authorities/Indian housing authorities, plus independent school districts. The FOA also explicitly notes additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and tribal organizations (including those other than federally recognized tribal governments, as specified). At the same time, the FOA clearly restricts foreign participation: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
Administratively, this opportunity is offered by the National Institutes of Health. The published purpose statement is straightforward: to transition COBRE core resources and biomedical research activities into independence and sustainability. The full announcement was made available through the NIH Grants Guide at the provided link (http://grants.nih.gov/grants/guide/pa-files/PAR-14-178.html). For technical issues accessing the announcement or linking to it, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, the FOA can be understood as a capstone-stage COBRE funding pathway. Rather than launching new capacity from scratch, it supports maturing centers that already have functioning cores and research momentum, and it pushes them toward a stable future where the shared resources, services, and research programs built under COBRE can continue operating and supporting competitive biomedical research with decreasing reliance on the COBRE mechanism.
FAQs: Limited Competition COBRE Phase III Transitional Centers (P30) - PAR-14-178
What is this funding opportunity?
This opportunity is the Limited Competition Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers (P30) program (Funding Opportunity Number PAR-14-178). It is a discretionary NIH grant program intended to help established COBRE programs transition from structured, programmatic COBRE support to long-term independence and financial sustainability.
What is the main purpose of COBRE Phase III (Transitional Centers) funding?
The purpose is to transition COBRE core resources and the biomedical research activities that rely on those cores into independence and sustainability. Practically, this means maintaining and strengthening COBRE-developed shared core resources while center leadership and the institution implement durable plans for continuing the center without COBRE program support.
What does "Phase III" mean in the COBRE context?
"Phase III" indicates a capstone-stage mechanism for COBRE centers that have progressed through earlier development stages and have already built meaningful research capacity. NIH support under this FOA is described as a bridge to independence, rather than a permanent subsidy.
What type of grant mechanism is used?
The funding instrument is a P30 center core grant. P30 awards generally emphasize shared infrastructure, centralized resources, and services that support multiple investigators and enable stronger research than individual investigators might be able to achieve on their own.
What kinds of activities does a P30 Transitional Center support under this FOA?
Based on the description provided, the FOA focuses on keeping essential COBRE-developed cores and related research capabilities operating effectively, while supporting the transition planning needed for the center to become self-sustaining through other funding streams, institutional investment, user fees, partnerships, or other sustainable models.
Is this opportunity intended to create new COBRE centers?
No. The FOA is described as supporting maturing centers that already have functioning cores and research momentum. It is positioned as a transition pathway for established COBRE programs rather than a mechanism to launch new capacity from scratch.
What is the maximum award amount (award ceiling)?
The award ceiling listed for this FOA is $750,000.
Is cost sharing or matching required?
No cost sharing or matching requirement is indicated. Applicants are not required to commit non-federal funds as a formal condition of the award. However, the description notes that NIH center applications commonly address institutional commitment and sustainability plans as part of competitive proposals.
Who offers this grant opportunity?
This opportunity is offered by the National Institutes of Health (NIH).
What is the CFDA number for this program?
The Catalog of Federal Domestic Assistance (CFDA) number provided is 93.859 (Biomedical Research and Research Training).
When was the opportunity posted and when did it close?
The program was posted on April 24, 2014. The original and final closing date was May 26, 2016. The archive date was June 26, 2016.
Where can the full announcement be found?
The full announcement is available through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PAR-14-178.html
What types of U.S. organizations are eligible to apply?
Eligibility is broad across many U.S.-based organization types. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, and a range of governmental entities (including state, county, city or township governments, special district governments, certain housing authorities/Indian housing authorities, and independent school districts).
Are any specific institution categories explicitly listed as eligible?
Yes. The FOA explicitly notes additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and tribal organizations (including those other than federally recognized tribal governments, as specified).
Can foreign organizations apply or participate as components?
No. The FOA restricts foreign participation: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
What does "transitional" mean for funded centers?
"Transitional" means NIH support is intended to help the center cross the gap between being COBRE-supported and being independently viable. The emphasis is on maintaining and strengthening core resources while establishing sustainable funding and operational models that reduce reliance on the COBRE mechanism over time.
What is the practical focus of the FOA?
In practical terms, it focuses on transitioning a COBRE that has already built meaningful research capacity into a stable, self-sustaining center by maintaining and strengthening its shared core resources and the biomedical research activities that depend on those cores.
Who should be contacted for technical issues with accessing the announcement link?
For technical issues accessing the announcement or linking to it, the listed contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Wolf Livestock Demonstration Project Grant Program (WLDPGP)
Previous opportunity: Alliance for Innovation on Maternal HealthImproving Maternal Health and Safety
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 14 178
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 14 178) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) Apply for PAR 14 192 Funding Number: PAR 14 192 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Epidemiology and Prevention in Alcohol Research (R21) Apply for PA 14 188 Funding Number: PA 14 188 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epidemiology and Prevention in Alcohol Research (R03) Apply for PA 14 189 Funding Number: PA 14 189 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Epidemiology and Prevention in Alcohol Research (R01) Apply for PA 14 190 Funding Number: PA 14 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for Tribal Behavioral Health Apply for SM 14 013 Funding Number: SM 14 013 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $200,000 |
| Emerging Pandemic Threats Program 2, PREDICT 2 Apply for RFA OAA 14 000019 Funding Number: RFA OAA 14 000019 Agency: Agency for International Development Category: Health Funding Amount: $100,000,000 |
| Sickle Cell Disease Treatment Demonstration Program Regional Collaborative Apply for HRSA 14 078 Funding Number: HRSA 14 078 Agency: Health Resources and Services Administration Category: Health Funding Amount: $850,000 |
| Immunization Information Systems (IIS) Capacity Building Apply for CDC RFA IP12 120103CONT14 Funding Number: CDC RFA IP12 120103CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partner and Implement Public Health Strategies Related to Apply for CDC RFA DP10 100305CONT14 Funding Number: CDC RFA DP10 100305CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Planning Grant for Global Infectious Disease Research Training Program (D71) Apply for PAR 14 194 Funding Number: PAR 14 194 Agency: National Institutes of Health Category: Health Funding Amount: $28,000 |
| Global Infectious Disease Research Training Program (D43) Apply for PAR 14 193 Funding Number: PAR 14 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Initiative for Minority Men (AIMM) Apply for MP CPI 14 002 Funding Number: MP CPI 14 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $375,000 |
| Centers of Excellence in Genomic Science (CEGS) (RM1) Apply for PAR 14 195 Funding Number: PAR 14 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 14 003 Funding Number: RFA NS 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Economic Studies of Vaccines and Immunization Policies, Programs, and Practices for Adults Apply for CDC RFA IP14 1403 Funding Number: CDC RFA IP14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Voluntary Medical Male Circumcision (VMMC), Early Infant Circumcision (EIMC) Service Delivery and Support to the Government of the Kingdom of Swaziland Apply for RFA 674 14 000001 Funding Number: RFA 674 14 000001 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $24,500,000 |
| Disseminating and Implementing Evidence from Patient Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21) Apply for RFA HS 14 010 Funding Number: RFA HS 14 010 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $150,000 |
| Emerging Pandemic Threats Program 2, Preparedness Apply for RFA OAA 14 000020 Funding Number: RFA OAA 14 000020 Agency: Agency for International Development Category: Health Funding Amount: $45,000,000 |
| Bridging the Word Gap Research Network Apply for HRSA 14 131 Funding Number: HRSA 14 131 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42) Apply for PA 14 196 Funding Number: PA 14 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 178", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.